Report Detail

Request for Sample of this report

Pharma & Healthcare Global Choroideremia Treatment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4533405
    • |
  • 08 June, 2023
    • |
  • Global
    • |
  • 104 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Choroideremia Treatment market size was valued at USD 3436.7 million in 2022 and is forecast to a readjusted size of USD 4766.9 million by 2029 with a CAGR of 4.8% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Choroideremia is an X-linked chorioretinal dystrophy characterized by the diffuse, progressive degeneration of the retinal pigment epithelium (RPE), photoreceptors and choriocapillaris. It is caused by a mutation in the CHM gene and is the focus of exciting basic and clinical research.
This report is a detailed and comprehensive analysis for global Choroideremia Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Choroideremia Treatment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Choroideremia Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Choroideremia Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Choroideremia Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Choroideremia Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Choroideremia Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis AG, Spark Therapeutics, Bluebird Bio Inc., Biogen and Copernicus Therapeutics, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Choroideremia Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oral
Intravenous
Market segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Major players covered
Novartis AG
Spark Therapeutics
Bluebird Bio Inc.
Biogen
Copernicus Therapeutics, Inc.
4D Molecular Therapeutics
Wize Pharma Inc.
Retina Implant AG
Hoffmann-La Roche Ltd
Pixium Vision
Merck
Teva
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Choroideremia Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Choroideremia Treatment, with price, sales, revenue and global market share of Choroideremia Treatment from 2018 to 2023.
Chapter 3, the Choroideremia Treatment competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Choroideremia Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Choroideremia Treatment market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Choroideremia Treatment.
Chapter 14 and 15, to describe Choroideremia Treatment sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Choroideremia Treatment
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Choroideremia Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Oral
    • 1.3.3 Intravenous
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Choroideremia Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital Pharmacies
    • 1.4.3 Retail Pharmacies
    • 1.4.4 Online Pharmacies
  • 1.5 Global Choroideremia Treatment Market Size & Forecast
    • 1.5.1 Global Choroideremia Treatment Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Choroideremia Treatment Sales Quantity (2018-2029)
    • 1.5.3 Global Choroideremia Treatment Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Novartis AG
    • 2.1.1 Novartis AG Details
    • 2.1.2 Novartis AG Major Business
    • 2.1.3 Novartis AG Choroideremia Treatment Product and Services
    • 2.1.4 Novartis AG Choroideremia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Novartis AG Recent Developments/Updates
  • 2.2 Spark Therapeutics
    • 2.2.1 Spark Therapeutics Details
    • 2.2.2 Spark Therapeutics Major Business
    • 2.2.3 Spark Therapeutics Choroideremia Treatment Product and Services
    • 2.2.4 Spark Therapeutics Choroideremia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Spark Therapeutics Recent Developments/Updates
  • 2.3 Bluebird Bio Inc.
    • 2.3.1 Bluebird Bio Inc. Details
    • 2.3.2 Bluebird Bio Inc. Major Business
    • 2.3.3 Bluebird Bio Inc. Choroideremia Treatment Product and Services
    • 2.3.4 Bluebird Bio Inc. Choroideremia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Bluebird Bio Inc. Recent Developments/Updates
  • 2.4 Biogen
    • 2.4.1 Biogen Details
    • 2.4.2 Biogen Major Business
    • 2.4.3 Biogen Choroideremia Treatment Product and Services
    • 2.4.4 Biogen Choroideremia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Biogen Recent Developments/Updates
  • 2.5 Copernicus Therapeutics, Inc.
    • 2.5.1 Copernicus Therapeutics, Inc. Details
    • 2.5.2 Copernicus Therapeutics, Inc. Major Business
    • 2.5.3 Copernicus Therapeutics, Inc. Choroideremia Treatment Product and Services
    • 2.5.4 Copernicus Therapeutics, Inc. Choroideremia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Copernicus Therapeutics, Inc. Recent Developments/Updates
  • 2.6 4D Molecular Therapeutics
    • 2.6.1 4D Molecular Therapeutics Details
    • 2.6.2 4D Molecular Therapeutics Major Business
    • 2.6.3 4D Molecular Therapeutics Choroideremia Treatment Product and Services
    • 2.6.4 4D Molecular Therapeutics Choroideremia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 4D Molecular Therapeutics Recent Developments/Updates
  • 2.7 Wize Pharma Inc.
    • 2.7.1 Wize Pharma Inc. Details
    • 2.7.2 Wize Pharma Inc. Major Business
    • 2.7.3 Wize Pharma Inc. Choroideremia Treatment Product and Services
    • 2.7.4 Wize Pharma Inc. Choroideremia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Wize Pharma Inc. Recent Developments/Updates
  • 2.8 Retina Implant AG
    • 2.8.1 Retina Implant AG Details
    • 2.8.2 Retina Implant AG Major Business
    • 2.8.3 Retina Implant AG Choroideremia Treatment Product and Services
    • 2.8.4 Retina Implant AG Choroideremia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Retina Implant AG Recent Developments/Updates
  • 2.9 Hoffmann-La Roche Ltd
    • 2.9.1 Hoffmann-La Roche Ltd Details
    • 2.9.2 Hoffmann-La Roche Ltd Major Business
    • 2.9.3 Hoffmann-La Roche Ltd Choroideremia Treatment Product and Services
    • 2.9.4 Hoffmann-La Roche Ltd Choroideremia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Hoffmann-La Roche Ltd Recent Developments/Updates
  • 2.10 Pixium Vision
    • 2.10.1 Pixium Vision Details
    • 2.10.2 Pixium Vision Major Business
    • 2.10.3 Pixium Vision Choroideremia Treatment Product and Services
    • 2.10.4 Pixium Vision Choroideremia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Pixium Vision Recent Developments/Updates
  • 2.11 Merck
    • 2.11.1 Merck Details
    • 2.11.2 Merck Major Business
    • 2.11.3 Merck Choroideremia Treatment Product and Services
    • 2.11.4 Merck Choroideremia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Merck Recent Developments/Updates
  • 2.12 Teva
    • 2.12.1 Teva Details
    • 2.12.2 Teva Major Business
    • 2.12.3 Teva Choroideremia Treatment Product and Services
    • 2.12.4 Teva Choroideremia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Teva Recent Developments/Updates

3 Competitive Environment: Choroideremia Treatment by Manufacturer

  • 3.1 Global Choroideremia Treatment Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Choroideremia Treatment Revenue by Manufacturer (2018-2023)
  • 3.3 Global Choroideremia Treatment Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Choroideremia Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Choroideremia Treatment Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Choroideremia Treatment Manufacturer Market Share in 2022
  • 3.5 Choroideremia Treatment Market: Overall Company Footprint Analysis
    • 3.5.1 Choroideremia Treatment Market: Region Footprint
    • 3.5.2 Choroideremia Treatment Market: Company Product Type Footprint
    • 3.5.3 Choroideremia Treatment Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Choroideremia Treatment Market Size by Region
    • 4.1.1 Global Choroideremia Treatment Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Choroideremia Treatment Consumption Value by Region (2018-2029)
    • 4.1.3 Global Choroideremia Treatment Average Price by Region (2018-2029)
  • 4.2 North America Choroideremia Treatment Consumption Value (2018-2029)
  • 4.3 Europe Choroideremia Treatment Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Choroideremia Treatment Consumption Value (2018-2029)
  • 4.5 South America Choroideremia Treatment Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Choroideremia Treatment Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Choroideremia Treatment Sales Quantity by Type (2018-2029)
  • 5.2 Global Choroideremia Treatment Consumption Value by Type (2018-2029)
  • 5.3 Global Choroideremia Treatment Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Choroideremia Treatment Sales Quantity by Application (2018-2029)
  • 6.2 Global Choroideremia Treatment Consumption Value by Application (2018-2029)
  • 6.3 Global Choroideremia Treatment Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Choroideremia Treatment Sales Quantity by Type (2018-2029)
  • 7.2 North America Choroideremia Treatment Sales Quantity by Application (2018-2029)
  • 7.3 North America Choroideremia Treatment Market Size by Country
    • 7.3.1 North America Choroideremia Treatment Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Choroideremia Treatment Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Choroideremia Treatment Sales Quantity by Type (2018-2029)
  • 8.2 Europe Choroideremia Treatment Sales Quantity by Application (2018-2029)
  • 8.3 Europe Choroideremia Treatment Market Size by Country
    • 8.3.1 Europe Choroideremia Treatment Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Choroideremia Treatment Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Choroideremia Treatment Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Choroideremia Treatment Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Choroideremia Treatment Market Size by Region
    • 9.3.1 Asia-Pacific Choroideremia Treatment Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Choroideremia Treatment Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Choroideremia Treatment Sales Quantity by Type (2018-2029)
  • 10.2 South America Choroideremia Treatment Sales Quantity by Application (2018-2029)
  • 10.3 South America Choroideremia Treatment Market Size by Country
    • 10.3.1 South America Choroideremia Treatment Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Choroideremia Treatment Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Choroideremia Treatment Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Choroideremia Treatment Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Choroideremia Treatment Market Size by Country
    • 11.3.1 Middle East & Africa Choroideremia Treatment Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Choroideremia Treatment Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Choroideremia Treatment Market Drivers
  • 12.2 Choroideremia Treatment Market Restraints
  • 12.3 Choroideremia Treatment Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Choroideremia Treatment and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Choroideremia Treatment
  • 13.3 Choroideremia Treatment Production Process
  • 13.4 Choroideremia Treatment Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Choroideremia Treatment Typical Distributors
  • 14.3 Choroideremia Treatment Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Choroideremia Treatment. Industry analysis & Market Report on Choroideremia Treatment is a syndicated market report, published as Global Choroideremia Treatment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Choroideremia Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,745.72
    		4,118.58
    		5,491.44
    		3,201.60
    		4,802.40
    		6,403.20
    		539,991.60
    		809,987.40
    		1,079,983.20
    		290,580.00
    		435,870.00
    		581,160.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo